The World Health Organization (WHO) has announced the prequalification of Cecolin, a new human papillomavirus (HPV) vaccine, for use in a single-dose schedule. This significant decision, announced on Friday, follows the evaluation of new data that meets the criteria outlined in WHO's 2022 recommendations for